Cargando…
Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in HIV-Infected and -Uninfected Children in South Africa: A Matched Case-Control Study
Background. South Africa introduced 7-valent pneumococcal conjugate vaccine (PCV7) in April 2009 using a 2 + 1 schedule (6 and 14 weeks and 9 months). We estimated the effectiveness of ≥2 PCV7 doses against invasive pneumococcal disease (IPD) in human immunodeficiency virus (HIV)–infected and -uninf...
Ejemplares similares
-
Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003 - 2008
por: Cohen, Cheryl, et al.
Publicado: (2015) -
Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
por: Meiring, Susan, et al.
Publicado: (2016) -
Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013
por: von Mollendorf, Claire, et al.
Publicado: (2016) -
Mortality amongst Patients with Influenza-Associated Severe Acute Respiratory Illness, South Africa, 2009-2013
por: Cohen, Cheryl, et al.
Publicado: (2015) -
The South African National HIV Pregnancy Cohort: evaluating continuity of care among women living with HIV
por: Clouse, Kate, et al.
Publicado: (2020)